Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2020-09-01
2021-04-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Online Self-management Program for Spinal Cord Injury: Feasibility Study of SCI&U
NCT04474171
Improving Self-Management Skills Among People With Spinal Cord Injury
NCT03140501
Understanding Experiences of People With Spinal Cord Injury Undergoing Activity-based Rehabilitation
NCT04000256
Enhancing Self-Efficacy for Caregivers of Family Members With Spinal Cord Injury
NCT02392052
Circuit Training Program for Persons With Spinal Cord Injury
NCT04263272
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
User Manuals for both the Client (i.e. Patient) and Provider (i.e. Clinician) are provided and contain screenshots and descriptive text that outline all the features of the intervention.
Patient participants will either be inpatients or outpatients, whereas healthcare team participants will consist of any provider assigned to the patient participant's circle of care at Parkwood Institute. The patient participants can choose to have their caregiver also access the platform - however, due to technical limitations, only 1 account is provided for the patient/caregiver dyad. Health care provider participants will have access to the platform for a specific patient at any time that patient is in the "Platform access" group as described below. The inpatient participants will be randomly allocated to 1 of 2 groups - either 1) "Platform access" or 2) "Standard care" with delayed access to the platform. In the "Standard care" group, the platform will be provided 6 weeks after inpatient discharge with support provided by the VIP coach. Those in the "Platform access" group will receive access within 2 weeks of admission to the inpatient or outpatient team at Parkwood Institute. For those patients transitioning from inpatient to outpatient care, their access to the platform will be guided by which group they were originally assigned to in addition to their needs and discharge circumstances as some of these patients may or may not be picked up by the Parkwood Outpatient team. The criteria influencing this will continue to be guided by the clinical team as per standard care. Participants seen by the outpatient team that were previously enrolled as inpatients in the "Standard care" group will be able to access the platform after 6 weeks of outpatient therapy with VIP coach support only, while those in the "Platform access" group can continue to use the platform with their outpatient health care providers.
Patient participants will complete surveys at specific time points throughout the study including measures at baseline (within 2 weeks of admission), discharge from inpatient program (or 6 weeks from admission for outpatients) and then 6 weeks after that. In the case of the "Standard care" group, there will be an additional follow-up survey to assess outcome measures 6 weeks after they have been provided access to the platform. The outcome measures will assess feasibility, usability, usage analytics and several patient-reported outcomes including self-management-related outcomes, healthcare utilization and prevalence of secondary complications.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Inpatient - Standard Care Delayed Platform
Patient will receive standard inpatient care and provided access to the platform 6 weeks after inpatient discharge with support provided by the VIP coach.
VIP4SCI
Technology-enabled self-management \& rehabilitation solution
Inpatient - Platform Access
Patient will be provided access to the platform within 2 weeks of admission to the inpatient program
VIP4SCI
Technology-enabled self-management \& rehabilitation solution
Outpatient - Platform Access
Patient will be provided access to the platform within 2 weeks of admission to the outpatient program. If patient is transitioning from the inpatient program, their access to the platform will be guided by which group they were originally assigned to (i.e. if a 6 week delay is applicable).
VIP4SCI
Technology-enabled self-management \& rehabilitation solution
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VIP4SCI
Technology-enabled self-management \& rehabilitation solution
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has a spinal cord injury
* Admitted to SCI inpatients/outpatients at Parkwood Institute for comprehensive Rehabilitation Care (not short stay)
* Has reliable high-speed internet access and device
* Intact cognitive function
\- Have been identified by the patient participant as someone who they would like to participate in a caregiver role
\- Part of the health care team for a patient participant
Exclusion Criteria
* No spinal cord injury
* No access to reliable internet access or device
* Impaired cognitive function
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ForaHealthyMe Inc
UNKNOWN
University Health Network, Toronto
OTHER
Spinal Cord Injury Ontario
UNKNOWN
The Craig H. Neilsen Foundation
OTHER
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dalton Wolfe
Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dalton Wolfe, PhD
Role: PRINCIPAL_INVESTIGATOR
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
115501
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.